
Momentum, NSE Universe
Midcap Smallcap momentum strategy
40 stocks, fortnightly rotation. Momentum on the NSE Universe under 2000.
Written for investors who want growth but read a 25% drawdown as opportunity, not panic.
Moderately High risk band

Momentum, NSE Universe
40 stocks, fortnightly rotation. Momentum on the NSE Universe under 2000.
Written for investors who want growth but read a 25% drawdown as opportunity, not panic.
Moderately High risk band
01At a glance
₹100 in the model in May 2021 became ₹737 by Jul 2026; the Nifty 50 TRI line reached ₹162. Model, back tested. As of 27 Apr 2026. After charges, log scale. Not a promise of future returns.
02Three steps
Line Midcap Smallcap up against the other 17 strategies, and against funds, PMS and AIF.
Compare strategiesEvery year, month, fall, holding and rebalance is in the factsheet below.
Open the factsheetLink your broker and approve each rebalance. Stocks stay in your own demat; RupeeCase never holds your money.
Invest in Midcap Smallcap03Factsheet
Every figure behind the four numbers, in seven parts. Return figures are model, back tested and after charges; each block names its date.
Model, back tested, after charges, 2021 to May 2026. Not a promise of future returns.
Model, back tested: the published monthly model returns after charges, May 2021 to May 2026 (61 months). A back test, not a promise of future returns.
Move across the record to read how far the model sat below its last peak, and how long it took to climb back.
Model, back tested. As of 27 Apr 2026. The scrub reads month end model values from May 2021 to Jul 2026, so its falls read shallower than the daily figures on the buttons; days are counted between month ends. Drawdowns of similar size can happen again. Moderately High risk band.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | Janno data | Febno data | Marno data | Aprno data | May3.1 | Jun16.7 | Jul8.7 | Aug−4.5 | Sep7.0 | Oct0.9 | Nov−0.3 | Dec16.8 | Year+56.9% |
| 2022 | Jan2.7 | Feb−12.0 | Mar5.8 | Apr4.5 | May−7.7 | Jun1.4 | Jul10.3 | Aug7.1 | Sep−0.4 | Oct3.3 | Nov6.4 | Dec4.9 | Year+26.9% |
| 2023 | Jan−8.2 | Feb−6.6 | Mar2.4 | Apr9.2 | May6.2 | Jun11.7 | Jul16.9 | Aug13.4 | Sep2.0 | Oct4.6 | Nov12.5 | Dec9.7 | Year+98.3% |
| 2024 | Jan11.3 | Feb2.2 | Mar−3.8 | Apr12.0 | May7.3 | Jun12.0 | Jul3.5 | Aug7.9 | Sep7.2 | Oct−5.8 | Nov8.5 | Dec3.2 | Year+86.0% |
| 2025 | Jan−10.9 | Feb−14.1 | Mar5.2 | Apr−0.1 | May10.9 | Jun1.9 | Jul−2.6 | Aug2.8 | Sep−2.7 | Oct−1.6 | Nov−2.1 | Dec7.1 | Year−8.7% |
| 2026 | Jan−1.3 | Feb5.7 | Mar−12.1 | Apr17.4 | May5.0 | Junno data | Julno data | Augno data | Sepno data | Octno data | Novno data | Decno data | Year to date+13.0% |
Model, back tested, after charges. Each cell is one calendar month, in percent. Not a promise of future returns.
Return over each 12 month window.
CAGR over each 36 month window.
Model, back tested, from the month end model values, May 2021 to Jul 2026. Not a promise of future returns.
Model, back tested, daily record over rolling 5 years: from the peak to the low, and the days until the record was back at that peak.
Live quantities, prices and book values are in the app
Weights on the rebalance day, 11 May 2026; they drift with prices until the next rebalance. Model portfolio, not a recommendation to buy or sell any stock.
11 sectors in the equity sleeve; the largest mapped sector is Power & Utilities at 17.5%, and 27.5% of the sleeve is not yet in the sector map. Wide sector spread across power/energy, metals, capital markets, pharma/health, telecom, cap goods, NBFC, and micro/sme segments. Sector map curated against NSE listings.
| Sector | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | Now |
|---|---|---|---|---|---|---|---|
| Other, not yet mapped | 71 | 71 | 73 | 71 | 73 | 40 | 19 |
| Capital Goods | 4 | 5 | 3 | 5 | 3 | 8 | 16 |
| Metals & Mining | 4 | 4 | 5 | 5 | 4 | 12 | 12 |
| Power & Utilities | 7 | 6 | 5 | 5 | 3 | 6 | 12 |
| FMCG & Consumer | 4 | 3 | 1 | 4 | 3 | 5 | 9 |
| Chemicals | 0 | 2 | 2 | 2 | 3 | 3 | 7 |
| IT & Technology | 4 | 1 | 2 | 1 | 2 | 5 | 7 |
| Banking & Financial | 3 | 3 | 6 | 3 | 3 | 6 | 4 |
| Auto & Components | 1 | 1 | 2 | 0 | 1 | 6 | 4 |
| Pharma & Healthcare | 0 | 0 | 2 | 2 | 2 | 3 | 4 |
| Realty & Construction | 0 | 1 | 0 | 0 | 1 | 1 | 4 |
| Energy & Oil & Gas | 0 | 3 | 0 | 1 | 0 | 3 | 2 |
| Diversified | 0 | 0 | 0 | 0 | 0 | 0 | 2 |
| Textiles | 0 | 0 | 0 | 0 | 1 | 1 | out |
131 published rebalances, 14 sectors touched, 13 held on the latest list (8 May 2026). Each cell is the average weight that year, equal weighted at the stock level; darker is a higher weight.
Rebalances run on a fixed calendar; you approve each one before your broker places the orders.
Against the list of 24 Apr 2026: 17 in, 24 out, 40 held, 57 on the list.
Model portfolio, back tested rebalance record. Entered plus held is that date's list size, which can differ from the 40 stock target. Tickers are not recommendations.
| Date | On the list | In | Out |
|---|---|---|---|
| 8 May 2026 | 57 | +17 | −24 |
| 24 Apr 2026 | 64 | +23 | −14 |
| 10 Apr 2026 | 55 | +14 | −4 |
| 27 Mar 2026 | 45 | +4 | −13 |
| 13 Mar 2026 | 54 | +5 | −6 |
| 27 Feb 2026 | 55 | +13 | −12 |
| 13 Feb 2026 | 54 | +12 | −17 |
| 30 Jan 2026 | 59 | +19 | −9 |
| 16 Jan 2026 | 49 | +9 | −8 |
| 2 Jan 2026 | 48 | +6 | −7 |
| 19 Dec 2025 | 49 | +7 | −16 |
| 5 Dec 2025 | 58 | +11 | −10 |
Every rebalance with its namesRebalance history, CSV
Names on the list, names in and names out at each date; the history page and the CSV have every name.
4 such shifts in 131 rebalances; the latest six. Equity sleeve, equal weighted at the stock level.
| Metric | Midcap Smallcap | Nifty 50 |
|---|---|---|
| Sharpe ratio | 1.63 | 0.73 |
| Sortino ratio | 1.48 | 0.70 |
| Calmar ratio | 1.91 | 0.58 |
| Volatility, a year | 27.02% | 14.04% |
| Max drawdown | −26.17% | −16.92% |
| Best week | +9.60% | +6.36% |
| Worst week | −13.44% | −6.33% |
| Weeks up | 65.13% | 57.47% |
| Average up week | +2.98% | +1.49% |
| Average down week | −3.13% | −1.57% |
Model, back tested, after charges. Weekly figures over the rolling 5 years window to 27 Apr 2026; the Nifty 50 over the same window. Not a promise of future returns.
Moderately High on a scale from Low to Very High
CAGR, Sharpe and max drawdown on the cards: Model, back tested. As of 27 Apr 2026. Take the risk profile to see which bands sit within yours.
Start from the NSE Universe, filtered to stocks priced under ₹2,000.
Score every stock in the universe by a momentum composite: price trend over several look backs, risk adjusted. The top names by score become the candidate list.
Hold the top 40 names by score, equal weighted so no single name dominates.
Every 2 weeks the model runs again end to end. Names that fall out of the top 40 are sold; new entrants are bought. The full list is published at every rebalance.

The design leans on breadth and hit frequency. Forty names spread single-stock risk thin, and the fortnightly screen keeps the portfolio rotating into whatever the mid and small-cap tape currently rewards. Wins do not need to be huge when they come often enough. Frequency does the compounding work.
The regime risk is real. Mid and small caps correct as a segment, and when they do, this card goes down with them and stays down until the segment turns. Drawdowns here are measured in months, not weeks. That is the price of running the segment with no debt or gold cushion.
What you get for sitting through that is the full mid and small-cap engine when the regime is on. The strong stretches on this card have historically been very strong, and the recoveries come from the same breadth that spreads the risk.
The card buys only stocks priced under 2000, the practical filter that maps the NSE Universe down to actively-tradeable mid and small-cap names. It rebalances every 2 weeks regardless of regime. It holds 40 names equal-weight. No fixed-income buffer. No gold sleeve. No defensive overlay.
Each rebalance publishes the full list, and the roster typically spans power and renewables, capital goods, metals, pharma, capital markets, and a long tail of smaller names. The current holdings and the next rebalance date sit alongside this card and update on schedule.
This is not a starter card. If you have not lived through a small-cap correction, start with Nifty 50 Equal Weight or a multi-asset card and graduate. This is also not a tax-friendly product if traded in a non-registered account.
The numbers beside this card do the talking on performance. The structure they measure does not change.
A description of the strategy, not a recommendation. Decide your own allocation, or ask a SEBI registered investment adviser.
Machine learning is used in research to search and optimise the model behind each strategy: which signals rank the universe, how many names to hold and how often to rebalance, tested out of sample. The rule that ships is then frozen and published, so the live strategy is a fixed, readable algorithm, not a black box that changes on its own.
Free modules from the RupeeCase Learn library. No sign up.
0.2%of traded value, charged only when a rebalance trades
Higher turnover or more capital raises the fee in proportion.
Model, back tested, cumulative over the rolling 5 years window to 27 Apr 2026. Net is gross minus estimated costs, as on the current factsheet. Not a promise of future returns.
RupeeCase is a technology platform, not a fund, a PMS or a SEBI registered investment adviser. Model, back tested. As of 27 Apr 2026. Model figures are after estimated charges and are not actual client returns. Past performance does not guarantee future returns; capital can be lost.
04Questions
40 stocks, fortnightly rotation. Pure mid and small-cap momentum. It selects the top 40 momentum names from NSE Universe (max 2000) and rebalances every 2 weeks.
About ₹80,000, enough to hold one share of every name in the current book at recent prices. The figure moves with the prices of the holdings.
Midcap Smallcap shows a model CAGR of 42.64% against 9.80% for the Nifty 50 TRI CAGR line (Jan 2021 to Jul 2026), with a Sharpe ratio of 1.63. Model, back tested. As of 27 Apr 2026. Past performance does not guarantee future returns.
26.17% peak to trough in the model record. The deepest period ran 497 days, from 20 Dec 2024 to 1 May 2026. Model, back tested. As of 27 Apr 2026. Drawdowns of similar size can happen again, so size the position for it.
0.2% of traded value per rebalance. No subscription, no AUM fee, no performance fee. On the minimum capital of ₹80,000, the platform fee works out to about ₹1,250 a year (1.56% of capital). Assumptions: 26 rebalances a year (every 2 weeks), 30% of the book traded at each rebalance, 0.2% of traded value. Higher turnover or more capital raises the fee in proportion. Broker side charges (brokerage, STT, exchange charges, GST) are separate.
Yes. No lock-in. Holdings sit in your own broker demat account and you can sell any name on any market day. Switching strategies or pausing the rebalance is a one-click action on the platform.
05Same family
HighMomentum
Midcap
Nifty Midcap 150, 20 stocks, every 2 weeks
CAGR, model38.75%Max DD−24.9%From₹90K
High risk, momentum
Moderately HighMomentum
Smallcap
Nifty Smallcap 250, 50 stocks, every 2 weeks
CAGR, model37.40%Max DD−22.3%From₹2.19L
Moderately High risk, momentum
Moderately HighMomentum
Microcap
Nifty Microcap 250, 50 stocks, every 2 weeks
CAGR, model37.33%Max DD−26.4%From₹2.25L
Moderately High risk, momentum
CAGR and Max DD on the cards: Model, back tested. As of 27 Apr 2026.
Explore next
Ready when you are
42.64% CAGR, model, back tested. About ₹80K to start. Every 2 weeks, you approve each one.
0.2% of traded value per rebalance. No AUM fee, no lock in. Line behind: the Midcap Smallcap model record, after charges, as of 27 Apr 2026. Not a promise of future returns.